Surgery is more cost-effective than splinting for carpal tunnel syndrome in the Netherlands: results of an economic evaluation alongside a randomized controlled trial

Table 5 Cost effectiveness and cost utility ratios (in EURO) (main analysis)*

Costs	Surgery (n = 73)**		Splint (n = 82)**		Ratio
	Costs	Effects	Costs	Effects
# Nights waking up due to complaints (0–7)	2,215	3.6	2,244	2.9	-40
Severity of the main complaint (0–10)	2,215	6.4	2,244	5.1	-21
Paraesthesia during the day (0–10)	2,215	5.5	2,244	4.0	-19
Paraesthesia at night (0–10)	2,215	5.2	2,244	4.5	-40
Utility (EuroQol; 0–1)***	2,126	0.85	2,111	0.81	353

EURO 1 = US $0.90; *Presented are the mean (standard deviation) improvements from baseline; ** Patients with missing data on either outcome measures or costs are excluded; *** Number of patients for utility in surgery (n = 79) and splint (n = 88).

ISSN: 1471-2474